MedTrace Logo

Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults

NCT05582239 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2023-05-17

No results posted yet for this study

Summary

This study is a prospective, multicentric, observational test negative design study on adults hospitalized for Severe Acute Respiratory Infection (SARI), regardless of their vaccination status.

Conditions

Sponsors & Collaborators

  • P95

    collaborator INDUSTRY

  • I-REIVAC

    collaborator UNKNOWN

  • EPICONCEPT

    collaborator UNKNOWN

  • Institut de Recherche en Santé Publique, France

    collaborator OTHER

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-20
Primary Completion
2026-01-20
Completion
2026-01-20

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05582239 on ClinicalTrials.gov